The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers

Int J Gynecol Cancer. 2022 Jun 15:ijgc-2022-003709. doi: 10.1136/ijgc-2022-003709. Online ahead of print.

Robert Dood^{1

2}, Britton Trabert^{3

2}, Theresa L Werner^{2

4}, David Gaffney^{2

5}, Elke Jarboe^{2

6}

¹ Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA robdood@gmail.com.
² University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA.
³ Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA.
⁴ Department of Medicine, The University of Utah School of Medicine, Salt Lake City, Utah, USA.
⁵ Department of Radiation Oncology, The University of Utah School of Medicine, Salt Lake City, Utah, USA.
⁶ Department of Pathology, The University of Utah School of Medicine, Salt Lake City, Utah, USA.

No abstract available

Keywords: Endometrial Neoplasms; Pathology; Radiation Oncology.

Grants and funding